Back to results
CompletedPhase 1Phase 2

Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease

NCT00948259

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Pharmacologische Studiecentrum Chemnitz

Chemnitz, Germany

+2 additional locations

View on ClinicalTrials.gov
Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease — TrialFind